Galera Therapeutics, Inc., based in Malvern, PA, is a pioneering biopharmaceutical company dedicated to transforming radiotherapy for patients with cancer. With a focus on reducing radiotherapy-induced toxicities and improving the anti-cancer efficacy of radiation therapy, Galera Therapeutics is developing novel therapies that prioritize the well-being and outcomes of patients receiving radiotherapy.
Through their first-in-class science, Galera Therapeutics leverages superoxide dismutase mimetics to address the challenges associated with radiotherapy. By pioneering a new scientific approach, the company aims to improve treatment options and outcomes for patients with cancer, ultimately revolutionizing the field of radiotherapy.
Generated from the website